APA (7th ed.) Citation

KC, K. Y., MB, G., M, A., Q, A., P, R., P, G., . . . MAT, H. (2026). Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality. Transplantation direct, 12(6), e1935. https://doi.org/10.1097/TXD.0000000000001935

Chicago Style (17th ed.) Citation

KC, Kosako Yost, et al. "Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality." Transplantation Direct 12, no. 6 (2026): e1935. https://doi.org/10.1097/TXD.0000000000001935.

MLA (9th ed.) Citation

KC, Kosako Yost, et al. "Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality." Transplantation Direct, vol. 12, no. 6, 2026, p. e1935, https://doi.org/10.1097/TXD.0000000000001935.